BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21471339)

  • 1. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
    Veguilla V; Hancock K; Schiffer J; Gargiullo P; Lu X; Aranio D; Branch A; Dong L; Holiday C; Liu F; Steward-Clark E; Sun H; Tsang B; Wang D; Whaley M; Bai Y; Cronin L; Browning P; Dababneh H; Noland H; Thomas L; Foster L; Quinn CP; Soroka SD; Katz JM
    J Clin Microbiol; 2011 Jun; 49(6):2210-5. PubMed ID: 21471339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population.
    Lerdsamran H; Pittayawonganon C; Pooruk P; Mungaomklang A; Iamsirithaworn S; Thongcharoen P; Kositanont U; Auewarakul P; Chokephaibulkit K; Oota S; Pongkankham W; Silaporn P; Komolsiri S; Noisumdaeng P; Chotpitayasunondh T; Sangsajja C; Wiriyarat W; Louisirirotchanakul S; Puthavathana P
    PLoS One; 2011 Jan; 6(1):e16164. PubMed ID: 21283570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.
    Hsu JP; Zhao X; Chen MI; Cook AR; Lee V; Lim WY; Tan L; Barr IG; Jiang L; Tan CL; Phoon MC; Cui L; Lin R; Leo YS; Chow VT
    BMC Infect Dis; 2014 Jul; 14():414. PubMed ID: 25066592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
    Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
    Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
    J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.
    Rowe T; Abernathy RA; Hu-Primmer J; Thompson WW; Lu X; Lim W; Fukuda K; Cox NJ; Katz JM
    J Clin Microbiol; 1999 Apr; 37(4):937-43. PubMed ID: 10074505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, Mongolia.
    Burmaa A; Tsatsral S; Odagiri T; Suzuki A; Oshitani H; Nymadawa P
    Influenza Other Respir Viruses; 2012 Nov; 6(6):e97-e104. PubMed ID: 22329794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus.
    Papenburg J; Baz M; Hamelin MÈ; Rhéaume C; Carbonneau J; Ouakki M; Rouleau I; De Serres G; Boivin G
    Clin Vaccine Immunol; 2011 Mar; 18(3):520-2. PubMed ID: 21228145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
    Allwinn R; Geiler J; Berger A; Cinatl J; Doerr HW
    Med Microbiol Immunol; 2010 May; 199(2):117-21. PubMed ID: 20162304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of serological assays to detect human antibodies to the avian influenza A H7N9 virus.
    Dong L; Bo H; Bai T; Gao R; Dong J; Zhang Y; Guo J; Zou S; Zhou J; Zhu Y; Xin L; Li X; Xu C; Wang D; Shu Y
    PLoS One; 2014; 9(4):e95612. PubMed ID: 24755627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte binding preference of human pandemic influenza virus a and its effect on antibody response detection.
    Makkoch J; Prachayangprecha S; Payungporn S; Chieochansin T; Songserm T; Amonsin A; Poovorawan Y
    Ann Lab Med; 2012 Jul; 32(4):276-82. PubMed ID: 22779069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and serological investigations of the Influenza A(H1N1) 2009 pandemic virus in Turkey.
    Akcay Ciblak M; Hasoksuz M; Kanturvardar M; Asar S; Badur S
    Med Microbiol Immunol; 2013 Aug; 202(4):277-84. PubMed ID: 23483248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
    BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus.
    Grund S; Adams O; Wählisch S; Schweiger B
    J Virol Methods; 2011 Feb; 171(2):369-73. PubMed ID: 21146560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.